We’re In The News

As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.

Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.

Tests for COVID-19: Has the FDA said yes too many times?

The Hill Opinion Contributors, May 6, 2020. Most tests being sold in the U.S. aren’t proven to be accurate by unbiased scientists. Here’s what you need to know.

Coronavirus Relief Act Gives Drug Makers New Sway Over FDA

Pogo, May 5, 2020. Under the $2 trillion coronavirus relief law, makers of over-the-counter drugs will pay the FDA to oversee their products and will gain new sway over the consumer protection agency.

What You Need to Know About the Malaria Drugs Trump Keeps Touting

Politico: April 6, 2020. The Trump administration is pushing ahead with a plan to “surge” the malaria drug hydroxychloroquine to coronavirus hot zones around the country, despite clear harms, including blindness and heart failure, and interactions with common medications.

FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments

NPR, March 25, 2020. FDA gives possible new drug to treat coronavirus orphan drug status, despite the fact that more than 200,000 people will ultimately get coronavirus.